Kembali ke Daftar Obat

Panduan penyiapan dan pemberian terapi medikasi
Esomeprazole

Penyiapan

Sediaan

  • 40 mg/vial

Rekomendasi Pengenceran (Konsentrasi)

  • 5 mL (IV bolus)
  • 50-100 mL (IV drip)

Pelarut

  • D5%
  • NaCl 0.9%
  • RL

Pemberian

Rekomendasi Akses

IV

Rekomendasi Durasi Pemberian

3 menit (IV bolus)
20-30 menit (IV bolus)

Stabilitas Obat Setelah Rekonstruksi

12 jam pada suhu ruang

Keamanan

pH

9,0-11,0
pH risiko tinggi (<4 / >9)

Osmolaritas Sebelum Pengenceran

300-350
Osmolaritas rendah (<600)

Phlebitis

Tidak

Inkompatibilitas

  • Tigecycline
  • Esmolol HCl
  • Labetalol HCl
  • Plazomicin Sulfate
  • Telavancin HCl

Klasifikasi GHS

Irritant

Manifestasi GHS

H312 (100%): Harmful in contact with skin [Warning Acute toxicity, dermal]
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
H317 (100%): May cause an allergic skin reaction [Warning Sensitization, Skin]
H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]
H412 (100%): Harmful to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard]

Sumber

  • https://www.medicines.org.uk/emc/product/4095/smpc#gref
  • https://pubchem.ncbi.nlm.nih.gov/compound/9568614
  • American Society of Health-System Pharmacists. 2021. ASHP® Injectable Drug Information: A Comprehensive Guide to Compatibility and Stability. 2021 Edition. eBook. American Society of Health-System Pharmacists. ISBN: 978-1-58528-690-4. doi.org/10.37573/9781585286850